IHS Chemical Week

Markets :: Specialty Chemicals :: Electronic chemicals

H.C. Starck Financial Performance Surges in 2011, Owners Mull Sale or IPO

1:29 PM MDT | April 3, 2012 | Sotirios Frantzanas

H.C. Starck's Ebitda increased 90% for full year 2011, to €190 million ($253 million ), according to figures published by Reuters citing sources close to H.C. Starck. H.C. Starck has not commented on the leaked Ebitda figures. The company has published sales figures showing that its 2011 sales increased 28% to €883.2 million compared with €689.3 million in 2010. The owners of the company, private equity groups Advent and Carlyle, are seeking to sell the group or to launch an IPO, sources told Reuters.  The owners of...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa